Literature DB >> 27117032

Development of a web-based tool for automated processing and cataloging of a unique combinatorial drug screen.

Alex G Dalecki1, Frank Wolschendorf2.   

Abstract

Facing totally resistant bacteria, traditional drug discovery efforts have proven to be of limited use in replenishing our depleted arsenal of therapeutic antibiotics. Recently, the natural anti-bacterial properties of metal ions in synergy with metal-coordinating ligands have shown potential for generating new molecule candidates with potential therapeutic downstream applications. We recently developed a novel combinatorial screening approach to identify compounds with copper-dependent anti-bacterial properties. Through a parallel screening technique, the assay distinguishes between copper-dependent and independent activities against Mycobacterium tuberculosis with hits being defined as compounds with copper-dependent activities. These activities must then be linked to a compound master list to process and analyze the data and to identify the hit molecules, a labor intensive and mistake-prone analysis. Here, we describe a software program built to automate this analysis in order to streamline our workflow significantly. We conducted a small, 1440 compound screen against M. tuberculosis and used it as an example framework to build and optimize the software. Though specifically adapted to our own needs, it can be readily expanded for any small- to medium-throughput screening effort, parallel or conventional. Further, by virtue of the underlying Linux server, it can be easily adapted for chemoinformatic analysis of screens through packages such as OpenBabel. Overall, this setup represents an easy-to-use solution for streamlining processing and analysis of biological screening data, as well as offering a scaffold for ready functionality expansion.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemoinformatics; Combinatorial screen; Copper; High throughput screen; Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27117032      PMCID: PMC4921064          DOI: 10.1016/j.mimet.2016.04.013

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  13 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  The FDA reboot of antibiotic development.

Authors:  David M Shlaes; Dan Sahm; Carol Opiela; Brad Spellberg
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

3.  Discovery research: the scientific challenge of finding new antibiotics.

Authors:  David M Livermore
Journal:  J Antimicrob Chemother       Date:  2011-06-23       Impact factor: 5.790

4.  Combating antimicrobial resistance: policy recommendations to save lives.

Authors:  Brad Spellberg; Martin Blaser; Robert J Guidos; Helen W Boucher; John S Bradley; Barry I Eisenstein; Dale Gerding; Ruth Lynfield; L Barth Reller; John Rex; David Schwartz; Edward Septimus; Fred C Tenover; David N Gilbert
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

5.  Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.

Authors:  Mehri Haeili; Casey Moore; Christopher J C Davis; James B Cochran; Santosh Shah; Tej B Shrestha; Yaofang Zhang; Stefan H Bossmann; William H Benjamin; Olaf Kutsch; Frank Wolschendorf
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

6.  Disulfiram and Copper Ions Kill Mycobacterium tuberculosis in a Synergistic Manner.

Authors:  Alex G Dalecki; Mehri Haeili; Santosh Shah; Alexander Speer; Michael Niederweis; Olaf Kutsch; Frank Wolschendorf
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

Review 7.  Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy.

Authors:  Kishor C Mehta; Ramesh R Dargad; Dhammraj M Borade; Onkar C Swami
Journal:  J Clin Diagn Res       Date:  2014-06-20

8.  Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

Authors:  Alexander Speer; Tej B Shrestha; Stefan H Bossmann; Randall J Basaraba; Gregory J Harber; Suzanne M Michalek; Michael Niederweis; Olaf Kutsch; Frank Wolschendorf
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

9.  Combinatorial phenotypic screen uncovers unrecognized family of extended thiourea inhibitors with copper-dependent anti-staphylococcal activity.

Authors:  Alex G Dalecki; Aruni P Malalasekera; Kaitlyn Schaaf; Olaf Kutsch; Stefan H Bossmann; Frank Wolschendorf
Journal:  Metallomics       Date:  2016-03-03       Impact factor: 4.526

Review 10.  Has the era of untreatable infections arrived?

Authors:  David M Livermore
Journal:  J Antimicrob Chemother       Date:  2009-09       Impact factor: 5.790

View more
  2 in total

1.  8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.

Authors:  Santosh Shah; Alex G Dalecki; Aruni P Malalasekera; Cameron L Crawford; Suzanne M Michalek; Olaf Kutsch; Jim Sun; Stefan H Bossmann; Frank Wolschendorf
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  High-throughput screening and Bayesian machine learning for copper-dependent inhibitors of Staphylococcus aureus.

Authors:  Alex G Dalecki; Kimberley M Zorn; Alex M Clark; Sean Ekins; Whitney T Narmore; Nichole Tower; Lynn Rasmussen; Robert Bostwick; Olaf Kutsch; Frank Wolschendorf
Journal:  Metallomics       Date:  2019-03-20       Impact factor: 4.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.